Joselin D Tacastacas, P. Oyetakin‐White, D. Soler, A. Young, S. Groft, K. Honda, K. Cooper, T. McCormick
{"title":"咪喹莫特预处理是否能优化308 nm准分子激光(UVB)治疗银屑病患者?","authors":"Joselin D Tacastacas, P. Oyetakin‐White, D. Soler, A. Young, S. Groft, K. Honda, K. Cooper, T. McCormick","doi":"10.1111/phpp.12299","DOIUrl":null,"url":null,"abstract":"Psoriasis continues to be a debilitating skin disease affecting 1–3% of the United States population. Although the effectiveness of several current biologic therapies have described this pathology as a IL‐23, TNF‐a and Th17‐mediated disease, less invasive approaches are still in use and in need of refinement. One of these is the usage of narrow band‐UVB (NB‐UVB) therapy to deplete specifically intra‐epidermal CD3+, CD4+ and CD8+ cells to clear psoriatic plaques.","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Does imiquimod pretreatment optimize 308‐nm excimer laser (UVB) therapy in psoriasis patients?\",\"authors\":\"Joselin D Tacastacas, P. Oyetakin‐White, D. Soler, A. Young, S. Groft, K. Honda, K. Cooper, T. McCormick\",\"doi\":\"10.1111/phpp.12299\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Psoriasis continues to be a debilitating skin disease affecting 1–3% of the United States population. Although the effectiveness of several current biologic therapies have described this pathology as a IL‐23, TNF‐a and Th17‐mediated disease, less invasive approaches are still in use and in need of refinement. One of these is the usage of narrow band‐UVB (NB‐UVB) therapy to deplete specifically intra‐epidermal CD3+, CD4+ and CD8+ cells to clear psoriatic plaques.\",\"PeriodicalId\":20060,\"journal\":{\"name\":\"Photodermatology\",\"volume\":\"38 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Photodermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/phpp.12299\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photodermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/phpp.12299","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Does imiquimod pretreatment optimize 308‐nm excimer laser (UVB) therapy in psoriasis patients?
Psoriasis continues to be a debilitating skin disease affecting 1–3% of the United States population. Although the effectiveness of several current biologic therapies have described this pathology as a IL‐23, TNF‐a and Th17‐mediated disease, less invasive approaches are still in use and in need of refinement. One of these is the usage of narrow band‐UVB (NB‐UVB) therapy to deplete specifically intra‐epidermal CD3+, CD4+ and CD8+ cells to clear psoriatic plaques.